Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Fusion Pharmaceuticals Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +2 vs. Q2 2021
- Shares held
- 27.9M
- +4.04M (+17.0%) vs. Q2 2021
- Total value
- $220.6M
- +$28.5M (+14.8%) vs. Q2 2021
- New holders
- 6
- 13 more added
- Sold out
- 4
- 9 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Johnson & Johnson | 3,670,516 | $29.1M | 2.55% | +3,670,516 | New |
| FMR LLC | 3,226,471 | $25.6M | 0.00% | +42,262+1.3% | Added |
| OrbiMed Advisors LLC | 3,224,770 | $25.5M | 0.28% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $24.7M | 0.03% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $23.3M | 3.00% | −25,935−0.9% | Reduced |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20.2M | 0.20% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,379 | $12.7M | 4.47% | +20.0% | Added |
| Federated Hermes, Inc. | 1,453,890 | $11.5M | 0.02% | +856,049+143.2% | Added |
| Perceptive Advisors LLC | 1,254,607 | $9.94M | 0.14% | −520,560−29.3% | Reduced |
| Rock Springs Capital Management LP | 948,327 | $7.51M | 0.16% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 858,012 | $6.79M | 0.03% | −17,129−2.0% | Reduced |
| Artal Group S.A. | 750,000 | $5.94M | 0.15% | 00.0% | Unchanged |
| 1832 Asset Management L.P. | 734,321 | $5.84M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 414,256 | $3.28M | 0.00% | −56,047−11.9% | Reduced |
| Victory Capital Management Inc | 267,703 | $2.12M | 0.00% | −1,920−0.7% | Reduced |
| Sio Capital Management, LLC | 259,763 | $2.06M | 0.66% | −6,344−2.4% | Reduced |
| Woodline Partners LP | 154,621 | $1.23M | 0.02% | +240.0% | Added |
| Morgan Stanley | 82,286 | $651.0K | 0.00% | +6,074+8.0% | Added |
| Sofinnova Investments, Inc. | 78,066 | $618.0K | 0.04% | +78,066 | New |
| AlphaCentric Advisors LLC | 71,500 | $566.0K | 0.14% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 43,394 | $344.0K | 0.01% | +43,394 | New |
| Sectoral Asset Management Inc | 38,198 | $303.0K | 0.03% | +38,198 | New |
| Millennium Management LLC | 26,925 | $213.0K | 0.00% | +26,925 | New |
| Geode Capital Management, LLC | 25,136 | $199.0K | 0.00% | +2,047+8.9% | Added |
| Goldman Sachs Group Inc | 20,149 | $160.0K | 0.00% | +1,928+10.6% | Added |
| DekaBank Deutsche Girozentrale | 13,000 | $105.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,298 | $35.0K | 0.00% | +473+12.4% | Added |
| JPMorgan Chase & Co | 2,991 | $24.0K | 0.00% | +948+46.4% | Added |
| Tower Research Capital LLC (TRC) | 2,654 | $21.0K | 0.00% | −361−12.0% | Reduced |
| Citigroup Inc | 2,414 | $19.0K | 0.00% | −160−6.2% | Reduced |
| Royal Bank of Canada | 2,350 | $19.0K | 0.00% | +1,200+104.3% | Added |
| Bank Julius Baer & Co. Ltd, Zurich | 2,000 | $16.0K | 0.00% | +20+1.0% | Added |
| Bank of America Corp | 1,401 | $11.0K | 0.00% | −924−39.7% | Reduced |
| Simplex Trading, LLC | 1,460 | $11.0K | 0.00% | +152+11.6% | Added |
| Penserra Capital Management LLC | 980 | $7.00K | 0.00% | +15+1.6% | Added |
| Signaturefd, LLC | 300 | $2.00K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 240 | $2.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 78 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 30 | $238 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 100 | $0 | 0.00% | +100 | New |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,180−100.0% | Sold out |
| Altfest L J & Co Inc | 0 | $0 | 0.00% | −10,213−100.0% | Sold out |
| Paragon Wealth Strategies, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Johnson & Johnson Innovation - JJDC, Inc. | – | – | – | – | Not filed |